Extracellular α-synuclein alters synaptic transmission in brain neurons by perforating the neuronal plasma membrane

Journal of Neurochemistry

Volumn 132, Issue 6, 2015, Pages 731-741

  Pacheco, Carla R ^a   Morales, Camila N ^a   Ramírez, Alejandra E ^a   Muñoz, Francisco J ^b   Gallegos, Scarlet S ^a   Caviedes, Pablo A ^c   Aguayo, Luis G ^a   Opazo, Carlos M ^d  

^a UNIVERSITY OF CONCEPCIÓN   (Chile)

^b UNIVERSITAT POMPEU FABRA   (Spain)

^c UNIVERSITY OF CHILE   (Chile)

^d FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

Author keywords

calcium; Parkinson's disease; perforation; pore like structures; synuclein

Indexed keywords

ALPHA SYNUCLEIN; GLUCOSE DERIVATIVE; MEMBRANE PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CARBOHYDRATE TRANSPORT; CONTROLLED STUDY; DEGENERATIVE DISEASE; EMBRYO; HIPPOCAMPUS; MEMBRANE CONDUCTANCE; NERVE CELL MEMBRANE; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; RAT; SYNAPSE VESICLE; SYNAPTIC TRANSMISSION; ANIMAL; BRAIN; CELL CULTURE; CELL MEMBRANE; CYTOLOGY; EXTRACELLULAR FLUID; FEMALE; METABOLISM; NERVE CELL; ORGAN CULTURE TECHNIQUE; PHYSIOLOGY; PREGNANCY; SPRAGUE DAWLEY RAT;

ALPHA-SYNUCLEIN; ANIMALS; BRAIN; CELL MEMBRANE; CELLS, CULTURED; EXTRACELLULAR FLUID; FEMALE; HIPPOCAMPUS; NEURONS; ORGAN CULTURE TECHNIQUES; PREGNANCY; RATS, SPRAGUE-DAWLEY; SYNAPTIC TRANSMISSION;

EID: 84924410540     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.13060     Document Type: Article

References (39)

1. Aarsland D., Bronnick K., Ehrt U., De Deyn P. P., Tekin S., Emre M., and, Cummings J. L., (2007) Neuropsychiatric symptoms in patients with Parkinson's disease and dementia: frequency, profile and associated care giver stress. J. Neurol. Neurosurg. Psychiatry 78, 36-42.
2. Bidinosti M., Shimshek D. R., Mollenhauer B., Marcellin D., Schweizer T., Lotz G. P., Schlossmacher M. G., and, Weiss A., (2012) Novel one-step immunoassays to quantify α-synuclein: applications for biomarker development and high-throughput screening. J. Biol. Chem. 287, 33691-33705.
3. Braak H., Ghebremedhin E., Rub U., Bratzke H., and, Del Tredici K., (2004) Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res. 318, 121-134.
4. Burre J., Vivona S., Diao J., Sharma M., Brunger A. T., and, Sudhof T. C., (2013) Properties of native brain α-synuclein. Nature 498, E4-E6.
5. Danzer K. M., Haasen D., Karow A. R., Moussaud S., Habeck M., Giese A., Kretzschmar H., Hengerer B., and, Kostka M., (2007) Different species of α-synuclein oligomers induce calcium influx and seeding. J. Neurosci. 27, 9220-9232.
6. El-Agnaf O. M., Salem S. A., Paleologou K. E., et al,. (2003) α-synuclein implicated in Parkinson's disease is present in extracellular biological fluids, including human plasma. FASEB J. 17, 1945-1947.
7. El-Agnaf O. M., Salem S. A., Paleologou K. E., Curran M. D., Gibson M. J., Court J. A., Schlossmacher M. G., and, Allsop D., (2006) Detection of oligomeric forms of α-synuclein protein in human plasma as a potential biomarker for Parkinson's disease. FASEB J. 20, 419-425.
8. Feng L. R., Federoff H. J., Vicini S., and, Maguire-Zeiss K. A., (2010) α-synuclein mediates alterations in membrane conductance: a potential role for α-synuclein oligomers in cell vulnerability. Eur. J. Neurosci. 32, 10-17.
9. Kim H. Y., Cho M. K., Kumar A., et al,. (2009) Structural properties of pore-forming oligomers of α-synuclein. J. Am. Chem. Soc. 131, 17482-17489.
10. Kostka M., Hogen T., Danzer K. M., et al,. (2008) Single particle characterization of iron-induced pore-forming α-synuclein oligomers. J. Biol. Chem. 283, 10992-11003.
11. Lashuel H. A., Hartley D., Petre B. M., Walz T., and, Lansbury P. T., Jr, (2002) Neurodegenerative disease: amyloid pores from pathogenic mutations. Nature 418, 291.
12. Lashuel H. A., Overk C. R., Oueslati A., and, Masliah E., (2013) The many faces of α-synuclein: from structure and toxicity to therapeutic target. Nat. Rev. Neurosci. 14, 38-48.
13. Lundblad M., Decressac M., Mattsson B., and, Bjorklund A., (2012) Impaired neurotransmission caused by overexpression of α-synuclein in nigral dopamine neurons. Proc. Natl Acad. Sci. USA 109, 3213-3219.
14. Mattson M. P., (2007) Calcium and neurodegeneration. Aging Cell 6, 337-350.
15. Opazo C., Huang X., Cherny R. A., et al,. (2002) Metalloenzyme-like activity of Alzheimer's disease β-amyloid. Cu-dependent catalytic conversion of dopamine, cholesterol, and biological reducing agents to neurotoxic H2O2. J. Biol. Chem. 277, 40302-40308.
16. Pacheco C., Aguayo L. G., and, Opazo C., (2012) An extracellular mechanism that can explain the neurotoxic effects of α-synuclein aggregates in the brain. Front. Physiol. 3, 297.
17. Paleologou K. E., Kragh C. L., Mann D. M., Salem S. A., Al-Shami R., Allsop D., Hassan A. H., Jensen P. H., and, El-Agnaf O. M., (2009) Detection of elevated levels of soluble α-synuclein oligomers in post-mortem brain extracts from patients with dementia with Lewy bodies. Brain 132, 1093-1101.
18. Parodi J., Sepulveda F. J., Roa J., Opazo C., Inestrosa N. C., and, Aguayo L. G., (2010) β-amyloid causes depletion of synaptic vesicles leading to neurotransmission failure. J. Biol. Chem. 285, 2506-2514.
19. Peters C., Munoz B., Sepulveda F. J., Urrutia J., Quiroz M., Luza S., De Ferrari G. V., Aguayo L. G., and, Opazo C., (2011) Biphasic effects of copper on neurotransmission in rat hippocampal neurons. J. Neurochem. 119, 78-88.
20. Peters C., Fernandez-Perez E. J., Burgos C. F., Espinoza M. P., Castillo C., Urrutia J. C., Streltsov V. A., Opazo C., and, Aguayo L. G., (2013) Inhibition of amyloid β-induced synaptotoxicity by a pentapeptide derived from the glycine zipper region of the neurotoxic peptide. Neurobiol. Aging 34, 2805-2814.
21. Quist A., Doudevski I., Lin H., Azimova R., Ng D., Frangione B., Kagan B., Ghiso J., and, Lal R., (2005) Amyloid ion channels: a common structural link for protein-misfolding disease. Proc. Natl Acad. Sci. USA 102, 10427-10432.
22. Relini A., Cavalleri O., Rolandi R., and, Gliozzi A., (2009) The two-fold aspect of the interplay of amyloidogenic proteins with lipid membranes. Chem. Phys. Lipids 158, 1-9.
23. van Rooijen B. D., Claessens M. M., and, Subramaniam V., (2010) Membrane interactions of oligomeric α-synuclein: potential role in Parkinson's disease. Curr. Protein Pept. Sci. 11, 334-342.
24. Schmidt F., Levin J., Kamp F., Kretzschmar H., Giese A., and, Botzel K., (2012) Single-channel electrophysiology reveals a distinct and uniform pore complex formed by α-synuclein oligomers in lipid membranes. PLoS ONE 7, e42545.
25. Sepulveda F. J., Parodi J., Peoples R. W., Opazo C., and, Aguayo L. G., (2010) Synaptotoxicity of Alzheimer ß amyloid can be explained by its membrane perforating property. PLoS ONE, 5, e11820.
26. Sepulveda F. J., Fierro H., Fernandez E., Castillo C., Peoples R. W., Opazo C., and, Aguayo L. G., (2014) Nature of the neurotoxic membrane actions of amyloid-ß on hippocampal neurons in Alzheimer's disease. Neurobiol. Aging, 35, 472-481.
27. Sharma M., Burre J., and, Sudhof T. C., (2011) CSPα promotes SNARE-complex assembly by chaperoning SNAP-25 during synaptic activity. Nat. Cell Biol. 13, 30-39.
28. Spillantini M. G., Crowther R. A., Jakes R., Hasegawa M., and, Goedert M., (1998) α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies. Proc. Natl Acad. Sci. USA 95, 6469-6473.
29. Surgucheva I., Sharov V. S., and, Surguchov A., (2012) γ-Synuclein: seeding of α-synuclein aggregation and transmission between cells. Biochemistry 51, 4743-4754.
30. Surguchov A., (2013) Synucleins: are they two-edged swords? J. Neurosci. Res. 91, 161-166.
31. Tapia J. C., Mentis G. Z., Navarrete R., Nualart F., Figueroa E., Sanchez A., and, Aguayo L. G., (2001) Early expression of glycine and GABA(A) receptors in developing spinal cord neurons. Effects on neurite outgrowth. Neuroscience 108, 493-506.
32. Tokuda T., Qureshi M. M., Ardah M. T., et al,. (2010) Detection of elevated levels of α-synuclein oligomers in CSF from patients with Parkinson disease. Neurology 75, 1766-1772.
33. Tsigelny I. F., Bar-On P., Sharikov Y., et al,. (2007) Dynamics of α-synuclein aggregation and inhibition of pore-like oligomer development by β-synuclein. FEBS J. 274, 1862-1877.
34. Tsigelny I. F., Crews L., Desplats P., et al,. (2008) Mechanisms of hybrid oligomer formation in the pathogenesis of combined Alzheimer's and Parkinson's diseases. PLoS ONE 3, e3135.
35. Tsigelny I. F., Sharikov Y., Wrasidlo W., Gonzalez T., Desplats P. A., Crews L., Spencer B., and, Masliah E., (2012) Role of α-synuclein penetration into the membrane in the mechanisms of oligomer pore formation. FEBS J. 279, 1000-1013.
36. Volles M. J., and, Lansbury P. T., Jr, (2002) Vesicle permeabilization by protofibrillar α-synuclein is sensitive to Parkinson's disease-linked mutations and occurs by a pore-like mechanism. Biochemistry 41, 4595-4602.
37. Volles M. J., and, Lansbury P. T., Jr, (2003) Zeroing in on the pathogenic form of α-synuclein and its mechanism of neurotoxicity in Parkinson's disease. Biochemistry 42, 7871-7878.
38. Winner B., Regensburger M., Schreglmann S., et al,. (2012) Role of α-synuclein in adult neurogenesis and neuronal maturation in the dentate gyrus. J. Neurosci. 32, 16906-16916.
39. Zakharov S. D., Hulleman J. D., Dutseva E. A., Antonenko Y. N., Rochet J. C., and, Cramer W. A., (2007) Helical α-synuclein forms highly conductive ion channels. Biochemistry 46, 14369-14379.